Literature DB >> 11177670

Translating heart failure guidelines into clinical practice: clinical science and the art of medicine.

K F Adams1.   

Abstract

The rapid growth of medical knowledge during the past few decades has created many potential advances in the therapeutics of chronic disease, and cardiovascular disease has been at the center of this phenomenon. Translation of these advances into everyday care of patients with chronic disease continues to be problematic. Guideline development has emerged as a major strategy to improve utilization of new and existing therapeutic modalities of proven benefit. To be effective, practice guidelines must not only clearly delineate which therapies are efficacious, but also consider the many practical aspects necessary for implementation of specific therapeutics in the actual care of patients. In this way, both the art and the science of medicine can be employed to obtain better patient outcomes in cardiovascular diseases long associated with severe mortality, morbidity, and poor quality of life. This review examines the difficulties inherent in translating new advances into standards of care. The recent guideline process for a specific chronic cardiovascular disease, heart failure, is used for illustration of the translation process.

Entities:  

Mesh:

Year:  2001        PMID: 11177670     DOI: 10.1007/s11886-001-0039-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  18 in total

Review 1.  beta-adrenergic receptor blockade in chronic heart failure.

Authors:  M R Bristow
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

Review 2.  Practice guidelines: a new reality in medicine. I. Recent developments.

Authors:  S H Woolf
Journal:  Arch Intern Med       Date:  1990-09

3.  The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

4.  Small area variations in health care delivery.

Authors:  J Wennberg
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

5.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

6.  Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?

Authors:  S Morimoto; K Shimizu; K Yamada; S Hiramitsu; H Hishida
Journal:  Am Heart J       Date:  1999-09       Impact factor: 4.749

7.  Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.

Authors:  F Waagstein; K Caidahl; I Wallentin; C H Bergh; A Hjalmarson
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

8.  Adrenergic effects on the biology of the adult mammalian cardiocyte.

Authors:  D L Mann; R L Kent; B Parsons; G Cooper
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).

Authors: 
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  2 in total

1.  Why do so few patients with heart failure participate in cardiac rehabilitation? A cross-sectional survey from England, Wales and Northern Ireland.

Authors:  Hasnain M Dalal; Jennifer Wingham; Joanne Palmer; Rod Taylor; Corinna Petre; Robert Lewin
Journal:  BMJ Open       Date:  2012-03-26       Impact factor: 2.692

2.  Heart failure guidelines and prescribing in primary care across Europe.

Authors:  Heidrun B Sturm; Wiek H van Gilst; Karl Swedberg; F D Richard Hobbs; Flora M Haaijer-Ruskamp
Journal:  BMC Health Serv Res       Date:  2005-08-30       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.